Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5185a564d68e277959d09ec10248a73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04a6e5a2cc96c0a220da4c0833c740e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 |
filingDate |
1995-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a45199870fdf49f680b1fa38fc71cb38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cbad2e22b66331e4f2312d9233aafe0 |
publicationDate |
1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9529169-A2 |
titleOfInvention |
Process for preparing 2-piperazine carboxylic acid derivatives |
abstract |
The invention concerns a process fro preparing 2-piperazine carboxylic acid amides of general formula (I), wherein a piperazine carboxylic acid, N-acylated with a halogenating agent to form a piperazine carboxylic acid anhydride of general formula (IV), is cycled and finally converted into the end product with an amino component. The 2-piperazine carboxylic acid amides of general formula (I) are inter alia valuable intermediate products for preparing orally active HIV-1 protease inhibitors. |
priorityDate |
1994-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |